Jenny Griffith

426 total citations
39 papers, 286 citations indexed

About

Jenny Griffith is a scholar working on Genetics, Rheumatology and Epidemiology. According to data from OpenAlex, Jenny Griffith has authored 39 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 17 papers in Rheumatology and 16 papers in Epidemiology. Recurrent topics in Jenny Griffith's work include Inflammatory Bowel Disease (20 papers), Microscopic Colitis (16 papers) and Rheumatoid Arthritis Research and Therapies (13 papers). Jenny Griffith is often cited by papers focused on Inflammatory Bowel Disease (20 papers), Microscopic Colitis (16 papers) and Rheumatoid Arthritis Research and Therapies (13 papers). Jenny Griffith collaborates with scholars based in United States, Germany and Canada. Jenny Griffith's co-authors include Arijit Ganguli, Keith A. Betts, Yan Song, M. Elaine Husni, Bryan McDonald, Zheng‐Yi Zhou, James Signorovitch, Edward V. Loftus, Kristina Kligys and George Reed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Jenny Griffith

35 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenny Griffith United States 12 123 97 95 75 60 39 286
Marie Teil United Kingdom 6 114 0.9× 44 0.5× 277 2.9× 27 0.4× 51 0.8× 11 443
P Müller Netherlands 10 87 0.7× 24 0.2× 55 0.6× 63 0.8× 71 1.2× 43 334
Ann D. Flynn United States 5 74 0.6× 39 0.4× 196 2.1× 36 0.5× 34 0.6× 11 315
Laura Watts United Kingdom 10 69 0.6× 46 0.5× 28 0.3× 20 0.3× 18 0.3× 14 234
Jeff Simpson United Kingdom 4 108 0.9× 23 0.2× 278 2.9× 19 0.3× 46 0.8× 7 401
Dapo Ilo United States 12 49 0.4× 230 2.4× 55 0.6× 165 2.2× 52 0.9× 34 355
D. Ruiz-Montesinos Spain 7 247 2.0× 16 0.2× 74 0.8× 16 0.2× 77 1.3× 21 317
C Popescu Romania 9 129 1.0× 11 0.1× 70 0.7× 56 0.7× 50 0.8× 48 257
René-Marc Flipo France 5 115 0.9× 18 0.2× 200 2.1× 15 0.2× 50 0.8× 6 320
Santiago Bernal‐Macías Colombia 9 142 1.2× 26 0.3× 52 0.5× 32 0.4× 42 0.7× 32 257

Countries citing papers authored by Jenny Griffith

Since Specialization
Citations

This map shows the geographic impact of Jenny Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Griffith more than expected).

Fields of papers citing papers by Jenny Griffith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Griffith. The network helps show where Jenny Griffith may publish in the future.

Co-authorship network of co-authors of Jenny Griffith

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Griffith. A scholar is included among the top collaborators of Jenny Griffith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Griffith. Jenny Griffith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sands, Bruce E., Silvio Danese, John C. Chapman, et al.. (2024). Mucosal and Transmural Healing and Long-term Outcomes in Crohn’s Disease. Inflammatory Bowel Diseases. 31(3). 857–877. 12 indexed citations
2.
3.
Feagan, Brian G., Remo Panaccione, Edward V. Loftus, et al.. (2024). Effect of Risankizumab Induction and Maintenance Therapy on the Rate of Hospitalization in Patients with Crohn’s Disease. SHILAP Revista de lepidopterología. 4(4). 100603–100603. 2 indexed citations
4.
Feagan, Brian G., Jean–Frédéric Colombel, Remo Panaccione, et al.. (2024). Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn’s Disease. SHILAP Revista de lepidopterología. 4(1). 100544–100544. 1 indexed citations
5.
Siegel, Corey A., et al.. (2024). Treatment Pathways in Patients With Crohn’s Disease and Ulcerative Colitis: Understanding the Road to Advanced Therapy. Crohn s & Colitis 360. 6(3). otae040–otae040. 2 indexed citations
6.
Colombel, Jean‐Frédéric, Stefan Schreiber, Geert D’Haens, et al.. (2023). Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn’s Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies. Journal of Crohn s and Colitis. 18(6). 818–827. 6 indexed citations
7.
8.
Ananthakrishnan, Ashwin N., Raj Desai, Wan‐Ju Lee, et al.. (2023). Economic Burden of Fatigue in Inflammatory Bowel Disease. Crohn s & Colitis 360. 5(3). otad020–otad020. 9 indexed citations
9.
Loftus, Edward V., Jenny Griffith, Ezequiel Neimark, et al.. (2023). Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease. Advances in Therapy. 40(5). 2311–2325. 9 indexed citations
10.
Spivey, Christina A., Kevin Winthrop, Jenny Griffith, et al.. (2019). Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis. Rheumatology and Therapy. 7(1). 133–147. 1 indexed citations
11.
12.
Harrold, Leslie R., Jenny Griffith, Patrick Zueger, et al.. (2019). Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry. The Journal of Rheumatology. 47(7). 959–967. 9 indexed citations
13.
Strand, Vibeke, M. Elaine Husni, Keith A. Betts, et al.. (2018). Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis. BMC Rheumatology. 2(1). 3–3. 13 indexed citations
14.
Kavanaugh, Arthur, Rakesh Singh, Chitra Karki, et al.. (2018). Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis. Clinical Rheumatology. 37(8). 2275–2280. 6 indexed citations
15.
Husni, M. Elaine, Keith A. Betts, Jenny Griffith, Yan Song, & Arijit Ganguli. (2017). Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective. Rheumatology International. 37(9). 1423–1434. 24 indexed citations
16.
Spivey, Christina A., Jenny Griffith, Cameron M. Kaplan, et al.. (2017). A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States. Rheumatology and Therapy. 5(1). 255–270. 14 indexed citations
17.
Brameld, Kate, et al.. (2017). Psychotropic Medication and Substance Use during Pregnancy by Women with Severe Mental Illness. Frontiers in Psychiatry. 8. 28–28. 3 indexed citations
18.
Betts, Keith A., Jenny Griffith, Arijit Ganguli, et al.. (2016). Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis. Clinical Therapeutics. 38(5). 1205–1216. 12 indexed citations
19.
Betts, Keith A., Jenny Griffith, Yan Song, et al.. (2016). Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis. Rheumatology and Therapy. 3(2). 323–336. 11 indexed citations
20.
Zachry, Woodie, et al.. (2009). Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting. Epilepsy & Behavior. 16(2). 268–273. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Teil Breakdown of academic impact, for papers by P Müller Breakdown of academic impact, for papers by Ann D. Flynn Breakdown of academic impact, for papers by Laura Watts Breakdown of academic impact, for papers by Jeff Simpson Breakdown of academic impact, for papers by Dapo Ilo Breakdown of academic impact, for papers by D. Ruiz-Montesinos Breakdown of academic impact, for papers by C Popescu Breakdown of academic impact, for papers by René-Marc Flipo Breakdown of academic impact, for papers by Santiago Bernal‐Macías
Rankless by CCL
2026